Boos-moog

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Boos-moog - overview

Location

-, -, Germany

Primary Industry

Healthcare

About

Boos-moog is a radiological and nuclear medicine practice in Germany, specializing in diagnostic imaging services including CT, MRI, and Nuclear Medicine. The company is committed to providing comprehensive healthcare solutions to its patients. Boos-moog operates as a radiological and nuclear medicine practice focused on delivering essential diagnostic services. Founded with the aim of enhancing healthcare access, the company has its headquarters in Germany.


Recently, in December 2020, Boos-moog was acquired by RAD-x SAS, a portfolio company of Gilde Healthcare Partners. The firm has completed a total of 1 deal as of the latest update. Boos-moog operates as a comprehensive radiological and nuclear medicine practice, providing essential diagnostic services to patients across multiple locations. Their core offerings include advanced imaging technologies such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Nuclear Medicine, alongside conventional X-rays and specialized procedures like Mammography and Prostate Imaging.


The firm serves a diverse clientele, including individual patients, local hospitals such as Ilmtalklinik Pfaffenhofen and Kreiskrankenhaus Schrobenhausen, and healthcare facilities in the surrounding regions. Their geographical market primarily encompasses the areas of Pfaffenhofen, Schrobenhausen, and Manching, ensuring accessibility to high-quality diagnostics and care for local communities. Boos-moog's revenue generation is primarily driven through direct service transactions with patients and partnerships with healthcare institutions. The company employs a service model where patients can schedule appointments for diagnostics, resulting in a fee-for-service structure.


Revenue is accrued on a per-visit basis, with patients potentially utilizing insurance coverage for the costs associated with their diagnostic procedures. The firm emphasizes patient-centric care, ensuring services are delivered in a timely manner despite fluctuations in demand. While specific pricing plans for individual services are not disclosed, the operational framework indicates a focus on facilitating efficient and accessible healthcare through a robust scheduling system. Boos-moog aims to enhance its service offerings by expanding into new geographic markets, although specific regions targeted for this expansion have not been disclosed.


The recent acquisition by RAD-x SAS in December 2020 is expected to provide the necessary resources to support further growth initiatives. The company is currently assessing its strategic direction post-acquisition, with plans to develop new products or services in the future.


Current Investors

RAD-x Management GmbH

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories

Website

www.boos-moog.de

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Boos-moog - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedBoos-moog-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.